Ademetionine 400 mg Tablet is a uniquely versatile product, and Salvus Pharma is offering a strategic PCD Pharma franchise for our brand, Adysil 400, in Hyderabad.
The Hyderabad Market Dynamic: Hyderabad is a major healthcare capital with some of the nation's top super-specialty hospitals. This market has two large, co-existing patient populations:
- A growing number of patients with liver conditions (like fatty liver) seeking hepato-protective support.
- A large, active, and aging population in need of effective solutions for osteoarthritis.
How Adysil 400 Meets the Demand: Adysil 400 (Ademetionine) is the perfect product for this dual market. It is a single, trusted medication prescribed by two different specialist groups:
- Gastroenterologists for its proven liver-protective benefits.
- Orthopedicians for its effective chondroprotective and pain-relieving properties in joint disease.
The Salvus Pharma Partnership Offer: We are offering the Ademetionine 400 mg PCD franchise in Hyderabad on an exclusive monopoly basis. This allows you to:
- Build a resilient business by serving two high-value specialist segments.
- Double your revenue streams with a single, WHO-GMP certified product.
- Receive targeted marketing support for both specialties.
Capture Two Markets in Hyderabad: To learn more about this unique Adysil 400 franchise opportunity, contact Salvus Pharma today. Contact Us: Call +91 9888902349 or email marketing@salvuspharma.in.
